SCHEMBL12463564

SCHEMBL12463564

COc1nc(Br)c(OC)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 3/20 0.52
MAPK1 P28482 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 3/20 0.52
CYP2C19 P33261 1/20 0.52
POLB P06746 1/20 0.47
MAPT P10636 2/20 0.39
NQO2 P16083 2/20 0.39
NR1I3 Q14994 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP3A4 P08684 1/20 0.36
VDR P11473 1/20 0.36
CYP2B6 P20813 1/20 0.36
AHR P35869 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SQOR Q9Y6N5 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13409722 0.84 ALDH1A1 (0.44) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL1536392 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL29850315 0.72 KDM4E (0.70) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL21906404 0.72 KDM4E (0.70) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL15491313 0.72 POLB (0.60) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL1536327 0.72 POLB (0.46) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL10693072 0.72 POLB (0.46) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL29366129 0.71 ALDH1A1 (1.00) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL52405 0.71 ALDH1A1 (1.00) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2
SCHEMBL11286804 0.71 ALDH1A1 (0.54) ALDH1A1KDM4EMAPK1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2340830-A2 Hepatitis C Virus Inhibitors Bristol-Myers Squibb Company (US) 2011-07-06 EP disclosed